维普期刊资源整合服务平台（V6.5）

26篇 您的检索式：作者名="Adamo ML"

选中清除导出查看参考文献查看引证文献引用追踪共2页首页上一页第1页下一页末页 /2 跳转

	题名	作者	年代	出处	被引量
1	Activation of peroxisome proliferator-activated receptor gamma (PPARgamma) by rosiglitazone suppresses components of the insulin-like growth factor regulatory system in vitro and in vivo显示文摘	Lecka-Czernik B Ackert-Bicknell C Adamo ML	2007	Endocrinology2007，148，2：	1
2	Phase II study of sor- afenib in patients with metastatic or recurrent sarcomas显示文摘	Maki RG D'Adamo DR Keohan ML	2009	J Clin Onco12009，27，19：	1
3	The role of insulin and insulin-like growth factor-Ⅰ in mammalian ageing显示文摘	Richardson A Liu F Adamo ML	2004	Best Pract Res Clin Endocrinol Metab2004，18，3：	1
4	Phase II study of sorafenib in patients with metastatic or recurrent sarcomas显示文摘	Maki RG D'Adamo DR Keohan ML		0，，：	1
5	The role of insulin and insulin-like growth factor-Ⅰ in mammalian ageing显示文摘	Richardson A Liu F Adamo ML Remmen HV Nelson JF		0，，03：	1
6	Osteogenic protein-1 and in-sulinlike growth factor I synergistically stimulate rat osteoblastic cell differentiation and proliferation显示文摘	Yeh LC Adamo ML Olson MS	1997	Endocrinology1997，138，10：	1
7	Current perspectives on Akt Akt-ivation and Akt-ions显示文摘	Matheny RW Jr Adamo ML	2009	Exp Biol Med (Maywood)2009，234，11：	1
8	Activation of peroxisome proliferator -activated receptor gamma (PPAR -gamma) by rosiglitazone suppresses components of the insulin-like growth factor regulatory system in vitro and in vivo显示文摘	Lecka-Czernik B Ackert-Bicknell C Adamo ML		0，，：	1
9	Insulin-like growth factor 1 physiology: lessons from mouse models 显示文摘	Yakar S Adamo ML	2012	Endocrinol Metab Clin North Am2012，41，2：	1
10	Phase II study of sorafenib in patients with metastatic or recurrent sarcomas显示文摘	Maki RG D' Adamo DR Keohan ML	2009	J Clin Oncol2009，27，19：	1
11	Activation of peroxisome proliferator-activated receptor gamma (PPARgamma) by rosiglitazone suppresses components of the insulin-like growth factor regulatory system in vitro and in vivo显示文摘	Lecka-Czemik B Ackert-Bicknell C Adamo ML	2007	Endocrinology2007，148，：	1
12	Activation of peroxisome proliferator--activated receptor gamma PPAR gama by rosiglitazone suppresses components of the insulin--llke growth factor regulatory system in vitro and in vivo显示文摘	Lecka-Czernik B Ackert-Bicknell C Adamo ML	2007	Endocrinology2007，148，2：	1
13	Cyclic AMP inhibits extracellular signalregulated kinase and phosphatidylinositol 3-kinase/Akt pathways by inhibiting Rap1显示文摘	Wang L Liu F Adamo ML	2001	J Biol Chem2001，276，37：	1
14	Clinical out- comes of systemic therapy for patients with deep fibromatosis ( des- mold tumor)显示文摘	de Camargo VP Keohan ML D'Adamo DR	2010	Cancer2010，116，9：	1
15	Phase Ⅱ study of sorafenib in patients with metastatic or recurrent sarcomas 显示文摘	Maki RG D'Adamo DR Keohan ML	2009	J Clin Oncol2009，27，：	1
16	Phase Ⅱ study of sorafenib in patients with metastatic or recurrent sarcomas显示文摘	Maki RG D'Adamo DR Keohan ML	2009	J Clin Oncol2009，27，：	1
17	Improved oxidative stress and cardio-metabolic status in obese prepubertal children with liver steatosis treated with lifestyle combined with Vitamin E显示文摘	D′ADAMO E MARCOVECCHIO ML GIANNINI C	2013	Free Radic Res2013，47，3：	1
18	Osteogenic protein-1 and insulin-like growth factor I synergistically stimulate rat osteoblastic cell differentiation and proliferation 显示文摘	Yeh LC Adamo ML Olson MS	1997	Endocrinology1997，138，10：	1
19	Clinical out- comes of systemic therapy for patients with deep fibromatosis (desmoid tumor)显示文摘	de Camargo VP Keohan ML D'Adamo DR	2010	Cancer2010，116，：	1
20	Activationof peroxisome proliferator-activated receptor gam- ma (PPARgamma) by rosiglitazone suppresses components of the insulin-like growthfactor regulatory system in vitro and in vivo 显示文摘	Lecka-Czemik B Ackert-Bicknell C Adamo ML	2007	Endocrinology2007，148，：	1

返回顶部每页显示：

共2页首页上一页第1页下一页末页 /2 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示